Tag archive


Healthcare has a $20B “Super” Problem: Precision Medicine is Here to Cut Costs and Save Lives

in Pharmaceutical Articles
Precision Medicine is Here to Cut Costs and Save Lives

In recent years, biotech, pharmaceutical and healthcare executives have been dealing with a global crisis created by the prevalence of multi-drug resistant organisms (MDROs), or as they have come to be referred to more commonly, superbugs. The Centers for Disease Control and Prevention (CDC) estimates that antibiotic-resistant infections are responsible for two million illnesses and 23,000 deaths annually in the U.S. alone. These infections are not only widespread, they can be costly and challenging as many healthcare facilities lack access…

Keep Reading

Proteomics International announces Strategic Alliance in CPR Pharma

in Pharmaceutical News
Proteomics International Laboratories Ltd PILL

Perth, W. Australia, Feb 12, 2018 – (ACN Newswire) – MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares. This alliance will see Proteomics International applying its Promarker discovery platform to formulate a new series of predictive diagnostics and analytical services capabilities…

Keep Reading

Go to Top